NovaBay Pharmaceuticals (NBY) Short Interest Ratio & Short Volume $0.72 +0.23 (+46.47%) (As of 09/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest NovaBay Pharmaceuticals Short Interest DataNovaBay Pharmaceuticals (NBY) has a short interest of 135,900 shares. This marks a -29.29% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 1.03 million shares to cover all short positions.Current Short Interest135,900 sharesPrevious Short Interest192,200 sharesChange Vs. Previous Month-29.29%Dollar Volume Sold Short$0.00Short Interest Ratio0.5 Days to CoverLast Record DateAugust 31, 2024Outstanding Shares4,210,000 sharesPercentage of Shares Shorted3.23%Today's Trading Volume145,328,232 sharesAverage Trading Volume1,029,726 sharesToday's Volume Vs. Average14,113% Short Selling NovaBay Pharmaceuticals? Sign up to receive the latest short interest report for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNBY Short Interest Over TimeNBY Days to Cover Over TimeNBY Percentage of Float Shorted Over Time Ad InvestorPlaceAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt industries worth over $46 trillion. What's even more intriguing?Click here to uncover how you can get in on the ground floor. NovaBay Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/31/2024135,900 shares $0.00 -29.3%N/A0.5 $0.00 8/15/2024192,200 shares $0.00 +495.1%N/A0.6 $0.00 7/31/202432,300 shares $0.00 -66.0%N/A0.1 $0.00 7/15/202494,900 shares $0.00 +27.0%N/A0.3 $0.00 6/30/202474,700 shares $0.00 +54.0%N/A0.2 $0.00 6/15/202448,500 shares $0.00 -92.5%N/A0.2 $0.00 Get the Latest News and Ratings for NBY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/31/2024647,600 shares $0.00 +2,023.3%84.7%2.3 $0.00 5/15/202430,500 shares $0.00 -77.7%0.1%0 $0.00 4/30/2024137,000 shares $0.00 -34.2%0.4%0.1 $0.00 4/15/2024208,100 shares $0.00 -71.1%0.6%0.1 $0.00 3/31/2024718,800 shares $0.00 +519.1%2.5%0.2 $0.00 3/15/2024116,100 shares $0.00 -57.3%0.4%0 $0.00 2/29/2024271,700 shares $0.00 -10.2%4.3%0.1 $0.00 2/15/2024302,400 shares $0.00 -47.6%4.8%0.1 $0.00 1/31/2024576,600 shares $0.00 +33.4%9.1%0.2 $0.00 1/15/2024432,400 shares $0.00 +1,226.4%6.8%0.6 $0.00 12/31/202332,600 shares $0.00 +136.2%0.5%0.1 $0.00 12/15/202313,800 shares $0.00 -58.7%0.2%0.1 $0.00 11/30/202333,400 shares $0.00 -40.8%0.5%0 $0.00 11/15/202356,400 shares $0.00 -39.1%0.9%0.1 $0.00 10/31/202392,600 shares $0.00 +21.5%2.3%0.1 $0.00 10/15/202376,200 shares $0.00 No Change1.9%0.1 $0.00 9/30/202376,200 shares $0.00 -73.0%1.9%0.1 $0.00 9/15/2023281,700 shares $0.00 +54.6%6.9%0.2 $0.00 8/31/2023182,200 shares $0.00 +0.9%4.5%0.2 $0.00 8/15/2023180,600 shares $0.00 +10.9%4.5%0.8 $0.00 7/31/2023162,900 shares $114,078.87 -43.4%4.0%0.3 $0.70 7/15/2023287,600 shares $0.00 -6.0%7.1%0.5 $0.00 6/30/2023305,900 shares $230,097.98 +9.8%7.6%0.6 $0.75 6/15/2023278,600 shares $186,076.94 +22.1%7.0%0.5 $0.67 5/31/2023228,100 shares $148,242.19 +53.6%9.1%0.5 $0.65 5/15/2023148,500 shares $0.00 -6.1%6.3%0.4 $0.00 4/30/2023158,100 shares $0.00 +81.7%8.3%1.7 $0.00 4/15/202387,000 shares $156,600.00 -2.9%5.0%1 $1.80 3/31/202389,600 shares $0.00 +3.9%5.2%3.3 $0.00 3/15/202386,200 shares $0.00 -10.2%5.0%1.9 $0.00 2/28/202396,000 shares $0.00 -3.1%5.5%1.9 $0.00 2/15/202399,100 shares $0.00 +0.1%5.7%1.7 $0.00 1/31/202399,000 shares $245,173.50 +3.0%5.7%1.4 $2.48 1/15/202396,100 shares $0.00 +115.5%5.6%1.4 $0.00Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on retiring any time soon... Every retirement dollar you have invested in paper assets will only continue to drop in value. We just released a Free Guide that reveals all the details.Click here to get the free Gold Guide now. 12/30/202244,600 shares $86,970.00 +8.0%2.8%0.6 $1.95 12/15/202241,300 shares $0.00 +7.8%N/A0.7 $0.00 11/30/202238,300 shares $0.00 +2.7%N/A0.6 $0.00 11/15/202237,300 shares $0.00 -96.6%N/A0.7 $0.00 10/31/20221,100,000 shares $0.00 -19.7%N/A0.8 $0.00 10/15/20221,370,000 shares $0.00 +88.0%N/A1 $0.00 9/30/2022728,800 shares $0.00 -17.4%N/A0.7 $0.00 9/15/2022881,900 shares $0.00 -48.1%N/A1.1 $0.00 8/31/20221,700,000 shares $0.00 -5.6%N/A2.8 $0.00 8/15/20221,800,000 shares $0.00 +30.4%N/A2.5 $0.00 7/31/20221,380,000 shares $0.00 +11.3%26.8%1.8 $0.00 7/15/20221,240,000 shares $0.00 -1.6%24.1%2 $0.00 6/30/20221,260,000 shares $0.00 -9.4%24.5%2 $0.00 6/15/20221,390,000 shares $0.00 +7.8%27.0%2.3 $0.00 5/31/20221,290,000 shares $0.00 +41.6%N/A2.2 $0.00 5/15/2022910,800 shares $0.00 -1.5%N/A2.1 $0.00 4/30/2022924,900 shares $0.00 +11.6%2.2%2.3 $0.00 4/15/2022828,800 shares $0.00 -9.8%2.0%2.1 $0.00 3/31/2022918,800 shares $272,240.44 -10.8%2.2%2.1 $0.30 3/15/20221,030,000 shares $0.00 +15.7%2.6%1.7 $0.00 2/28/2022890,200 shares $0.00 -7.1%2.3%1.3 $0.00 2/15/2022957,800 shares $0.00 -14.5%2.5%1.2 $0.00 1/31/20221,120,000 shares $0.00 -22.2%3.2%1.3 $0.00 1/15/20221,440,000 shares $0.00 -13.3%4.1%1.5 $0.00 12/31/20211,660,000 shares $0.00 -20.2%4.7%1.8 $0.00 12/15/20212,080,000 shares $0.00 -10.3%5.9%2.1 $0.00 11/30/20212,320,000 shares $0.00 +19.6%6.5%2.3 $0.00 11/15/20211,940,000 shares $0.00 +22.0%5.4%2.3 $0.00 10/29/20211,590,000 shares $842,700.00 -25.7%N/A1.8 $0.53 10/15/20212,140,000 shares $0.00 +5.9%6.0%1.3 $0.00 9/30/20212,020,000 shares $0.00 +4.7%5.7%1 $0.00 9/15/20211,930,000 shares $0.00 -6.8%5.4%1.1 $0.00 8/31/20212,070,000 shares $0.00 -5.1%5.9%1 $0.00 8/13/20212,180,000 shares $0.00 +29.8%6.2%1 $0.00 7/30/20211,680,000 shares $0.00 +44.8%5.2%0.8 $0.00 7/15/20211,160,000 shares $0.00 +8.4%3.6%1 $0.00 6/30/20211,070,000 shares $0.00 +29.3%3.3%1.3 $0.00 6/15/2021827,400 shares $0.00 -20.4%2.5%0.8 $0.00 5/28/20211,040,000 shares $0.00 +2.0%3.2%0.9 $0.00 5/14/20211,020,000 shares $0.00 -8.9%N/A0.6 $0.00 4/30/20211,120,000 shares $0.00 -9.7%N/A0.3 $0.00 4/15/20211,240,000 shares $954,800.00 +6.9%N/A0.3 $0.77 3/31/20211,160,000 shares $928,000.00 +13.7%N/A0.2 $0.80 3/15/20211,020,000 shares $856,800.00 +53.1%N/A0.2 $0.84 2/26/2021666,400 shares $673,064.00 -22.6%N/A0.1 $1.01 2/12/2021861,400 shares $783,874.00 -22.4%N/A0.2 $0.91 1/29/20211,110,000 shares $1.38 million +6.7%N/A0.4 $1.24 1/15/20211,040,000 shares $1.25 million +2.0%N/A0.4 $1.20 12/31/20201,020,000 shares $740,418.00 -22.7%N/A0.6 $0.73 12/15/20201,320,000 shares $918,588.00 +10.0%N/A0.9 $0.70Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on retiring any time soon... Every retirement dollar you have invested in paper assets will only continue to drop in value. We just released a Free Guide that reveals all the details.Click here to get the free Gold Guide now. 11/30/20201,200,000 shares $762,000.00 +26.3%N/A0.9 $0.64 11/15/2020950,500 shares $577,333.70 -1.8%N/A0.8 $0.61 10/30/2020968,000 shares $599,869.60 +18.0%N/A0.4 $0.62 10/15/2020820,100 shares $627,376.50 +106.3%N/A0.3 $0.77 9/30/2020397,500 shares $290,175.00 -22.8%N/A0.1 $0.73 9/15/2020515,100 shares $370,872.00 +0.8%N/A0.1 $0.72 8/31/2020511,200 shares $388,512.00 -6.4%N/A0.1 $0.76 8/14/2020546,200 shares $475,194.00 +12.0%N/A0.1 $0.87 7/31/2020487,900 shares $473,263.00 -60.7%N/A0.1 $0.97 7/15/20201,240,000 shares $1.53 million +267.4%N/A0.2 $1.23 6/30/2020337,500 shares $401,625.00 +35.5%1.7%0.1 $1.19 6/15/2020249,000 shares $288,840.00 +49.4%1.3%0.1 $1.16 5/29/2020166,700 shares $208,375.00 -55.8%1.0%0 $1.25 5/15/2020376,700 shares $320,195.00 +16.2%2.3%0.1 $0.85 4/30/2020324,300 shares $288,627.00 -20.5%1.9%0.1 $0.89 4/15/2020407,800 shares $411,878.00 +14.2%2.5%0.1 $1.01 3/31/2020357,000 shares $321,300.00 +150.0%2.2%0.2 $0.90 3/13/2020142,800 shares $107,100.00 +44.4%0.9%0.6 $0.75 2/28/202098,900 shares $89,999.00 -34.7%0.6%0.4 $0.91 2/14/2020151,400 shares $68,130.00 -53.5%0.9%0.5 $0.45 1/31/2020325,700 shares $192,163.00 -20.6%2.0%0.6 $0.59 1/15/2020410,200 shares $217,406.00 -20.2%2.5%0.7 $0.53 12/31/2019513,700 shares $339,042.00 -18.1%3.2%1 $0.66 NBY Short Interest - Frequently Asked Questions What is NovaBay Pharmaceuticals' current short interest? Short interest is the volume of NovaBay Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of August 31st, traders have sold 135,900 shares of NBY short. Learn More on NovaBay Pharmaceuticals' current short interest. Is NovaBay Pharmaceuticals' short interest increasing or decreasing? NovaBay Pharmaceuticals saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 135,900 shares, a decline of 29.3% from the previous total of 192,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does NovaBay Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to NovaBay Pharmaceuticals: GeoVax Labs, Inc. (11.35%), Cadrenal Therapeutics, Inc. (2.78%), NuCana plc (3.18%), Organovo Holdings, Inc. (0.61%), Aeterna Zentaris Inc. (0.18%), ABVC BioPharma, Inc. (1.31%), Mosaic ImmunoEngineering, Inc. (0.00%), Cardio Diagnostics Holdings, Inc. (2.01%), Coeptis Therapeutics Holdings, Inc. (0.31%), Pulmatrix, Inc. (0.14%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.11 billion), Canadian Natural Resources Limited ($4.04 billion), Suncor Energy Inc. ($3.19 billion), Aptiv PLC ($2.56 billion), Paychex, Inc. ($2.48 billion), Cencora, Inc. ($2.28 billion), Onsemi ($2.08 billion), Moderna, Inc. ($1.98 billion), Tractor Supply ($1.93 billion), and International Paper ($1.93 billion). View all of the most shorted stocks. What does it mean to sell short NovaBay Pharmaceuticals stock? Short selling NBY is an investing strategy that aims to generate trading profit from NovaBay Pharmaceuticals as its price is falling. NBY shares are trading up $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NovaBay Pharmaceuticals? A short squeeze for NovaBay Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NBY, which in turn drives the price of the stock up even further. How often is NovaBay Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NBY, twice per month. The most recent reporting period available is August, 31 2024. More Short Interest Resources from MarketBeat Related Companies: GOVX Short Interest Data CVKD Short Interest Data NCNA Short Interest Data ONVO Short Interest Data AEZS Short Interest Data ABVC Short Interest Data CPMV Short Interest Data CDIO Short Interest Data COEP Short Interest Data PULM Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:NBY) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredThe Perfect Storm for an EV RevoltWith constant talk about Artifical Intelligence, inflation, and the upcoming election clogging the airwaves......Eagle Publishing | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovaBay Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NovaBay Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
